Here’s what you should know.
1. The distributors’ assets consist of Cantel’s Medivators-branded products, which offer infection prevention solutions for endoscope reprocessing and endoscopy procedures.
2. Cantel CEO Jorgen B. Hansen said the acquisition will position the company in the Australian market. Cantel will distribute, service and support its products in the region.
3. The deal should close April 1, 2017. The companies didn’t disclose financial terms.
More articles on gastroenterology:
Takeda completes Ariad Pharmaceutical acquisition following NY law firm investigation — 3 GI companies making waves
GI leader to know: Dr. Shahab Aftahi of Estrella Gastroenterology
Versant Ventures launches Jecure Therapeutics: 4 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.